25 XP   0   0   10

Guangdong Taiantang Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Guangdong Taiantang Pharmaceutical Co Ltd together

PenkeI guess you are interested in Guangdong Taiantang Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Guangdong Taiantang Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Guangdong Taiantang Pharmaceutical Co Ltd

I send you an email if I find something interesting about Guangdong Taiantang Pharmaceutical Co Ltd.

Quick analysis of Guangdong Taiantang Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Guangdong Taiantang Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.01
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥4.52
Expected worth in 1 year
¥3.26
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
¥-1.18
Return On Investment
-91.0%

For what price can you sell your share?

Current Price per Share
¥1.30
Expected price per share
¥0 - ¥2.2
How sure are you?
50%

1. Valuation of Guangdong Taiantang Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥1.30

Intrinsic Value Per Share

¥-4.47 - ¥-5.56

Total Value Per Share

¥0.05 - ¥-1.05

2. Growth of Guangdong Taiantang Pharmaceutical Co Ltd (5 min.)




Is Guangdong Taiantang Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$479.3m$623.1m-$122.4m-24.5%

How much money is Guangdong Taiantang Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$32.2m-$51.9m$19.7m61.2%
Net Profit Margin-688.6%-56.5%--

How much money comes from the company's main activities?

3. Financial Health of Guangdong Taiantang Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Guangdong Taiantang Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Guangdong Taiantang Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Guangdong Taiantang Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Guangdong Taiantang Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Guangdong Taiantang Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Guangdong Taiantang Pharmaceutical Co Ltd is ¥1.3. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Guangdong Taiantang Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Guangdong Taiantang Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥4.52. Based on the TTM, the Book Value Change Per Share is ¥-0.31 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.47 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.02 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Guangdong Taiantang Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps-0.03-2.0%-0.01-1.0%-0.07-5.2%-0.01-0.7%0.000.0%
Usd Book Value Change Per Share-0.03-2.1%-0.04-3.3%-0.07-5.0%-0.02-1.2%0.010.5%
Usd Dividend Per Share0.000.0%0.000.2%0.000.3%0.010.4%0.010.5%
Usd Total Gains Per Share-0.03-2.1%-0.04-3.1%-0.06-4.7%-0.01-0.7%0.011.0%
Usd Price Per Share0.44-0.46-0.79-0.64-1.12-
Price to Earnings Ratio-4.12--11.76--17.70-15.16-35.04-
Price-to-Total Gains Ratio-16.05--33.65--113.88-89.84-102.44-
Price to Book Ratio0.70-0.70-0.97-0.73-1.60-
Price-to-Total Gains Ratio-16.05--33.65--113.88-89.84-102.44-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.17992
Number of shares5558
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share-0.04-0.02
Usd Total Gains Per Share-0.04-0.01
Gains per Quarter (5558 shares)-227.57-53.59
Gains per Year (5558 shares)-910.27-214.37
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
156-966-920129-343-224
2112-1933-1830258-687-438
3168-2899-2740387-1030-652
4224-3865-3650516-1374-866
5280-4831-4560645-1717-1080
6336-5798-5470774-2061-1294
7392-6764-6380903-2404-1508
8448-7730-72901032-2747-1722
9504-8697-82001162-3091-1936
10560-9663-91101291-3434-2150

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%2.010.00.016.7%10.010.00.050.0%30.010.00.075.0%45.010.00.081.8%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%9.011.00.045.0%29.011.00.072.5%43.012.00.078.2%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%51.00.04.092.7%
Total Gains per Share0.04.00.00.0%4.08.00.033.3%12.08.00.060.0%32.08.00.080.0%46.09.00.083.6%

Fundamentals of Guangdong Taiantang Pharmaceutical Co Ltd

About Guangdong Taiantang Pharmaceutical Co Ltd

Guangdong Taiantang Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese patent medicines in China. It offers medicines in the form of creams, ointments, tablets, capsules, pills, and solutions for reproductive health, skin health, cardiovascular, cerebrovascular, dermatology, anti-inflammatory, and other areas. The company also engages in processing and trading Chinese medicinal materials; and pharmaceutical e-commerce business. The company was founded in 2007 and is headquartered in Shantou, China.

Fundamental data was last updated by Penke on 2024-03-24 02:00:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Guangdong Taiantang Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Guangdong Taiantang Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Guangdong Taiantang Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -126.3% means that ¥-1.26 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Guangdong Taiantang Pharmaceutical Co Ltd:

  • The MRQ is -126.3%. The company is making a huge loss. -2
  • The TTM is -688.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-126.3%TTM-688.6%+562.3%
TTM-688.6%YOY-56.5%-632.1%
TTM-688.6%5Y-141.1%-547.5%
5Y-141.1%10Y-65.6%-75.5%
1.1.2. Return on Assets

Shows how efficient Guangdong Taiantang Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Guangdong Taiantang Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -2.4% Return on Assets means that Guangdong Taiantang Pharmaceutical Co Ltd generated ¥-0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Guangdong Taiantang Pharmaceutical Co Ltd:

  • The MRQ is -2.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.4%TTM-3.6%+1.2%
TTM-3.6%YOY-4.9%+1.3%
TTM-3.6%5Y-1.2%-2.4%
5Y-1.2%10Y-0.1%-1.1%
1.1.3. Return on Equity

Shows how efficient Guangdong Taiantang Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Guangdong Taiantang Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -4.4% Return on Equity means Guangdong Taiantang Pharmaceutical Co Ltd generated ¥-0.04 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Guangdong Taiantang Pharmaceutical Co Ltd:

  • The MRQ is -4.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -6.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.4%TTM-6.5%+2.1%
TTM-6.5%YOY-8.5%+1.9%
TTM-6.5%5Y-2.3%-4.2%
5Y-2.3%10Y-0.5%-1.8%

1.2. Operating Efficiency of Guangdong Taiantang Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Guangdong Taiantang Pharmaceutical Co Ltd is operating .

  • Measures how much profit Guangdong Taiantang Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Guangdong Taiantang Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -88.6% means the company generated ¥-0.89  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Guangdong Taiantang Pharmaceutical Co Ltd:

  • The MRQ is -88.6%. The company is operating very inefficient. -2
  • The TTM is -30.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-88.6%TTM-30.8%-57.8%
TTM-30.8%YOY-11.6%-19.2%
TTM-30.8%5Y-7.5%-23.3%
5Y-7.5%10Y-3.1%-4.4%
1.2.2. Operating Ratio

Measures how efficient Guangdong Taiantang Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 2.53 means that the operating costs are ¥2.53 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Guangdong Taiantang Pharmaceutical Co Ltd:

  • The MRQ is 2.529. The company is inefficient in keeping operating costs low. -1
  • The TTM is 0.663. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ2.529TTM0.663+1.866
TTM0.663YOY1.865-1.202
TTM0.6635Y1.534-0.871
5Y1.53410Y1.143+0.390

1.3. Liquidity of Guangdong Taiantang Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Guangdong Taiantang Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.00 means the company has ¥2.00 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Guangdong Taiantang Pharmaceutical Co Ltd:

  • The MRQ is 1.998. The company is able to pay all its short-term debts. +1
  • The TTM is 1.962. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.998TTM1.962+0.036
TTM1.962YOY2.247-0.285
TTM1.9625Y1.931+0.031
5Y1.93110Y1.076+0.855
1.3.2. Quick Ratio

Measures if Guangdong Taiantang Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Guangdong Taiantang Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.52 means the company can pay off ¥0.52 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Guangdong Taiantang Pharmaceutical Co Ltd:

  • The MRQ is 0.518. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.344. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.518TTM0.344+0.174
TTM0.344YOY0.569-0.225
TTM0.3445Y0.371-0.027
5Y0.37110Y0.441-0.070

1.4. Solvency of Guangdong Taiantang Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Guangdong Taiantang Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Guangdong Taiantang Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.43 means that Guangdong Taiantang Pharmaceutical Co Ltd assets are financed with 42.7% credit (debt) and the remaining percentage (100% - 42.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Guangdong Taiantang Pharmaceutical Co Ltd:

  • The MRQ is 0.427. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.427. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.427TTM0.4270.000
TTM0.427YOY0.402+0.026
TTM0.4275Y0.391+0.036
5Y0.39110Y0.330+0.061
1.4.2. Debt to Equity Ratio

Measures if Guangdong Taiantang Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Guangdong Taiantang Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 76.9% means that company has ¥0.77 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Guangdong Taiantang Pharmaceutical Co Ltd:

  • The MRQ is 0.769. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.770. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.769TTM0.770-0.001
TTM0.770YOY0.694+0.076
TTM0.7705Y0.669+0.101
5Y0.66910Y0.534+0.134

2. Market Valuation of Guangdong Taiantang Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Guangdong Taiantang Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Guangdong Taiantang Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -4.12 means the investor is paying ¥-4.12 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Guangdong Taiantang Pharmaceutical Co Ltd:

  • The EOD is -1.689. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.117. Based on the earnings, the company is expensive. -2
  • The TTM is -11.762. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.689MRQ-4.117+2.429
MRQ-4.117TTM-11.762+7.644
TTM-11.762YOY-17.700+5.939
TTM-11.7625Y15.161-26.923
5Y15.16110Y35.045-19.884
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Guangdong Taiantang Pharmaceutical Co Ltd:

  • The EOD is -1.782. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.345. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.449. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.782MRQ-4.345+2.563
MRQ-4.345TTM-2.449-1.896
TTM-2.449YOY188.503-190.952
TTM-2.4495Y33.261-35.710
5Y33.26110Y19.087+14.174
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Guangdong Taiantang Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Guangdong Taiantang Pharmaceutical Co Ltd:

  • The EOD is 0.288. Based on the equity, the company is cheap. +2
  • The MRQ is 0.702. Based on the equity, the company is cheap. +2
  • The TTM is 0.696. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.288MRQ0.702-0.414
MRQ0.702TTM0.696+0.006
TTM0.696YOY0.970-0.274
TTM0.6965Y0.733-0.037
5Y0.73310Y1.604-0.871
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Guangdong Taiantang Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.199-0.314+58%-0.471+137%-0.112-44%0.048-517%
Book Value Per Share--4.5174.719-4%5.873-23%6.386-29%5.913-24%
Current Ratio--1.9981.962+2%2.247-11%1.931+3%1.076+86%
Debt To Asset Ratio--0.4270.4270%0.402+6%0.391+9%0.330+29%
Debt To Equity Ratio--0.7690.7700%0.694+11%0.669+15%0.534+44%
Dividend Per Share--0.0010.018-93%0.032-96%0.042-97%0.046-97%
Eps---0.192-0.092-52%-0.490+154%-0.065-66%0.004-5563%
Free Cash Flow Per Share---0.1820.015-1326%0.102-279%0.042-529%-0.060-67%
Free Cash Flow To Equity Per Share---0.182-0.055-70%0.100-282%-0.070-62%-0.041-78%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---5.564--------
Intrinsic Value_10Y_min---4.467--------
Intrinsic Value_1Y_max--0.272--------
Intrinsic Value_1Y_min--0.268--------
Intrinsic Value_3Y_max--0.186--------
Intrinsic Value_3Y_min--0.190--------
Intrinsic Value_5Y_max---0.663--------
Intrinsic Value_5Y_min---0.561--------
Market Cap996804889.600-144%2430671044.0002524600761.000-4%4385942704.000-45%3567521017.250-32%6209524556.071-61%
Net Profit Margin---1.263-6.886+445%-0.565-55%-1.411+12%-0.656-48%
Operating Margin---0.886-0.308-65%-0.116-87%-0.075-91%-0.031-96%
Operating Ratio--2.5290.663+281%1.865+36%1.534+65%1.143+121%
Pb Ratio0.288-144%0.7020.696+1%0.970-28%0.733-4%1.604-56%
Pe Ratio-1.689+59%-4.117-11.762+186%-17.700+330%15.161-127%35.045-112%
Price Per Share1.300-144%3.1703.293-4%5.720-45%4.651-32%8.097-61%
Price To Free Cash Flow Ratio-1.782+59%-4.345-2.449-44%188.503-102%33.261-113%19.087-123%
Price To Total Gains Ratio-6.584+59%-16.055-33.646+110%-113.878+609%89.844-118%102.438-116%
Quick Ratio--0.5180.344+51%0.569-9%0.371+40%0.441+17%
Return On Assets---0.024-0.036+48%-0.049+102%-0.012-50%-0.001-95%
Return On Equity---0.044-0.065+49%-0.085+93%-0.023-48%-0.005-90%
Total Gains Per Share---0.197-0.296+50%-0.439+122%-0.070-65%0.094-310%
Usd Book Value--479361992.263500757337.533-4%623199174.960-23%677982021.711-29%627632263.774-24%
Usd Book Value Change Per Share---0.028-0.043+58%-0.065+137%-0.015-44%0.007-517%
Usd Book Value Per Share--0.6250.653-4%0.813-23%0.884-29%0.818-24%
Usd Dividend Per Share--0.0000.003-93%0.004-96%0.006-97%0.006-97%
Usd Eps---0.027-0.013-52%-0.068+154%-0.009-66%0.000-5563%
Usd Free Cash Flow---19356550.9481579168.307-1326%10813532.972-279%4510109.871-529%-4153221.597-79%
Usd Free Cash Flow Per Share---0.0250.002-1326%0.014-279%0.006-529%-0.008-67%
Usd Free Cash Flow To Equity Per Share---0.025-0.008-70%0.014-282%-0.010-62%-0.006-78%
Usd Market Cap137957796.721-144%336404872.490349404745.322-4%607014470.234-45%493744908.787-32%859398198.560-61%
Usd Price Per Share0.180-144%0.4390.456-4%0.792-45%0.644-32%1.121-61%
Usd Profit---20425367.899-32218246.416+58%-51947077.730+154%-11383552.104-44%-1871462.209-91%
Usd Revenue--16176280.78113999589.193+16%52460900.740-69%82709706.025-80%84598374.636-81%
Usd Total Gains Per Share---0.027-0.041+50%-0.061+122%-0.010-65%0.013-310%
 EOD+3 -5MRQTTM+16 -19YOY+13 -225Y+7 -2810Y+6 -29

3.2. Fundamental Score

Let's check the fundamental score of Guangdong Taiantang Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.689
Price to Book Ratio (EOD)Between0-10.288
Net Profit Margin (MRQ)Greater than0-1.263
Operating Margin (MRQ)Greater than0-0.886
Quick Ratio (MRQ)Greater than10.518
Current Ratio (MRQ)Greater than11.998
Debt to Asset Ratio (MRQ)Less than10.427
Debt to Equity Ratio (MRQ)Less than10.769
Return on Equity (MRQ)Greater than0.15-0.044
Return on Assets (MRQ)Greater than0.05-0.024
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Guangdong Taiantang Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5024.123
Ma 20Greater thanMa 501.733
Ma 50Greater thanMa 1002.048
Ma 100Greater thanMa 2002.361
OpenGreater thanClose1.300
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets6,046,960
Total Liabilities2,583,362
Total Stockholder Equity3,359,038
 As reported
Total Liabilities 2,583,362
Total Stockholder Equity+ 3,359,038
Total Assets = 6,046,960

Assets

Total Assets6,046,960
Total Current Assets3,428,117
Long-term Assets2,618,843
Total Current Assets
Cash And Cash Equivalents 34,254
Net Receivables 889,143
Inventory 2,260,614
Other Current Assets 244,105
Total Current Assets  (as reported)3,428,117
Total Current Assets  (calculated)3,428,117
+/- 0
Long-term Assets
Property Plant Equipment 1,833,772
Goodwill 21,464
Intangible Assets 251,738
Other Assets 200,244
Long-term Assets  (as reported)2,618,843
Long-term Assets  (calculated)2,307,218
+/- 311,625

Liabilities & Shareholders' Equity

Total Current Liabilities1,715,910
Long-term Liabilities867,452
Total Stockholder Equity3,359,038
Total Current Liabilities
Short Long Term Debt 759,656
Accounts payable 454,984
Other Current Liabilities 488,056
Total Current Liabilities  (as reported)1,715,910
Total Current Liabilities  (calculated)1,702,697
+/- 13,213
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt135
Other Liabilities 866,380
Long-term Liabilities  (as reported)867,452
Long-term Liabilities  (calculated)866,514
+/- 938
Total Stockholder Equity
Common Stock766,773
Other Stockholders Equity 2,368
Total Stockholder Equity (as reported)3,359,038
Total Stockholder Equity (calculated)769,141
+/- 2,589,897
Other
Capital Stock766,773
Common Stock Shares Outstanding 766,773
Net Debt 726,340
Net Invested Capital 4,119,632
Net Tangible Assets 3,085,836
Net Working Capital 1,712,207
Property Plant and Equipment Gross 1,833,772



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
> Total Assets 
336,886
1,037,164
969,238
992,778
998,936
1,037,200
1,216,579
1,393,910
1,389,141
1,409,776
1,518,011
2,177,310
2,206,274
2,300,818
2,425,442
2,555,750
2,584,095
2,732,799
4,120,426
4,493,310
4,556,978
4,515,255
4,721,173
5,868,858
6,374,046
6,522,026
6,558,336
6,879,186
7,172,653
7,438,646
7,950,705
8,154,976
8,357,310
8,331,823
8,504,836
8,675,109
8,783,446
8,714,427
8,737,022
8,804,983
9,067,502
9,144,511
8,957,822
9,077,059
8,877,328
8,131,264
8,184,530
7,628,959
7,546,338
7,471,254
7,467,016
6,562,516
6,349,409
6,321,754
6,046,960
6,046,9606,321,7546,349,4096,562,5167,467,0167,471,2547,546,3387,628,9598,184,5308,131,2648,877,3289,077,0598,957,8229,144,5119,067,5028,804,9838,737,0228,714,4278,783,4468,675,1098,504,8368,331,8238,357,3108,154,9767,950,7057,438,6467,172,6536,879,1866,558,3366,522,0266,374,0465,868,8584,721,1734,515,2554,556,9784,493,3104,120,4262,732,7992,584,0952,555,7502,425,4422,300,8182,206,2742,177,3101,518,0111,409,7761,389,1411,393,9101,216,5791,037,200998,936992,778969,2381,037,164336,886
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,453,262
4,602,623
4,520,360
4,536,261
4,368,707
4,440,306
4,247,978
4,469,375
4,505,013
4,419,507
4,669,460
4,502,691
4,451,202
4,538,057
4,463,924
4,434,799
4,388,538
4,414,776
3,596,883
3,486,266
3,489,185
3,428,117
3,428,1173,489,1853,486,2663,596,8834,414,7764,388,5384,434,7994,463,9244,538,0574,451,2024,502,6914,669,4604,419,5074,505,0134,469,3754,247,9784,440,3064,368,7074,536,2614,520,3604,602,6234,453,262000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
222,320
243,453
401,279
265,166
321,160
236,635
273,479
362,605
327,228
189,073
205,228
147,127
62,583
59,390
72,949
51,854
56,982
32,125
42,589
41,774
33,692
34,254
34,25433,69241,77442,58932,12556,98251,85472,94959,39062,583147,127205,228189,073327,228362,605273,479236,635321,160265,166401,279243,453222,320000000000000000000000000000000000
       Net Receivables 
75,914
77,735
85,856
74,561
94,871
112,099
121,180
137,211
142,273
147,483
172,439
197,760
181,445
215,970
269,379
306,911
300,016
314,823
318,030
282,708
338,050
350,013
322,217
293,900
388,053
458,683
457,667
537,803
514,001
567,516
555,626
764,619
780,049
776,087
787,286
1,339,376
535,738
479,179
500,090
915,320
756,674
697,217
707,462
851,930
615,527
963,153
829,579
1,071,386
1,036,749
1,193,674
1,176,231
319,417
295,211
924,759
889,143
889,143924,759295,211319,4171,176,2311,193,6741,036,7491,071,386829,579963,153615,527851,930707,462697,217756,674915,320500,090479,179535,7381,339,376787,286776,087780,049764,619555,626567,516514,001537,803457,667458,683388,053293,900322,217350,013338,050282,708318,030314,823300,016306,911269,379215,970181,445197,760172,439147,483142,273137,211121,180112,09994,87174,56185,85677,73575,914
       Other Current Assets 
7,999
4,298
122,874
53,918
52,820
93,207
83,623
75,465
84,178
89,638
84,475
54,663
54,854
50,900
36,435
80,668
55,781
125,785
626,125
103,153
137,100
124,336
153,325
180,842
195,080
308,359
302,178
177,077
180,813
214,683
280,662
263,470
292,252
242,095
346,215
276,176
64,168
56,345
62,433
241,927
357,889
427,109
406,435
347,816
501,965
678,427
871,837
356,322
379,082
357,665
294,865
66,354
65,328
252,257
244,105
244,105252,25765,32866,354294,865357,665379,082356,322871,837678,427501,965347,816406,435427,109357,889241,92762,43356,34564,168276,176346,215242,095292,252263,470280,662214,683180,813177,077302,178308,359195,080180,842153,325124,336137,100103,153626,125125,78555,78180,66836,43550,90054,85454,66384,47589,63884,17875,46583,62393,20752,82053,918122,8744,2987,999
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,247,185
4,345,720
4,296,717
4,557,005
4,598,127
4,639,498
4,538,316
4,407,598
4,374,636
3,680,062
3,646,473
3,165,035
3,111,539
3,082,716
3,052,240
2,965,633
2,863,142
2,832,568
2,618,843
2,618,8432,832,5682,863,1422,965,6333,052,2403,082,7163,111,5393,165,0353,646,4733,680,0624,374,6364,407,5984,538,3164,639,4984,598,1274,557,0054,296,7174,345,7204,247,185000000000000000000000000000000000000
       Property Plant Equipment 
143,808
161,323
156,683
283,702
305,986
336,006
304,644
415,333
441,083
523,827
568,546
693,499
748,910
814,967
783,106
821,850
775,309
796,531
835,805
840,668
916,804
984,626
1,074,139
1,138,057
1,164,294
1,340,497
1,431,867
1,950,171
2,069,821
2,263,897
2,543,372
2,600,745
2,665,394
2,653,438
2,682,079
2,630,945
2,722,720
2,801,462
2,751,802
2,588,306
2,621,199
2,594,328
2,603,302
2,564,909
2,545,137
2,506,810
2,502,753
2,315,144
2,280,622
2,250,327
2,219,435
2,147,674
2,065,825
2,032,643
1,833,772
1,833,7722,032,6432,065,8252,147,6742,219,4352,250,3272,280,6222,315,1442,502,7532,506,8102,545,1372,564,9092,603,3022,594,3282,621,1992,588,3062,751,8022,801,4622,722,7202,630,9452,682,0792,653,4382,665,3942,600,7452,543,3722,263,8972,069,8211,950,1711,431,8671,340,4971,164,2941,138,0571,074,139984,626916,804840,668835,805796,531775,309821,850783,106814,967748,910693,499568,546523,827441,083415,333304,644336,006305,986283,702156,683161,323143,808
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
130,191
146,746
146,746
445,075
445,075
445,075
445,075
445,075
445,075
445,075
445,075
445,075
445,075
445,075
445,075
466,539
466,539
466,539
466,539
466,539
466,539
466,539
466,539
466,539
466,539
466,539
466,539
466,539
466,539
151,655
151,655
21,464
21,464
21,464
21,464
21,464
21,464
21,464
21,464
21,46421,46421,46421,46421,46421,46421,46421,464151,655151,655466,539466,539466,539466,539466,539466,539466,539466,539466,539466,539466,539466,539466,539466,539445,075445,075445,075445,075445,075445,075445,075445,075445,075445,075445,075445,075146,746146,746130,1910000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
343,877
343,877
432,564
432,564
432,030
432,413
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000432,413432,030432,564432,564343,877343,877000000000000000000000000000000000
       Intangible Assets 
8,760
1,953
8,374
1,650
32,191
1,350
31,359
46,202
218,693
39,832
211,573
58,205
231,379
52,337
223,869
47,523
218,671
241,888
428,894
790,468
773,652
788,875
775,084
770,485
772,012
761,917
751,160
762,022
757,023
754,131
750,144
778,380
775,162
303,846
318,820
285,128
309,814
312,821
316,555
312,982
312,508
313,279
311,538
313,870
310,251
255,554
226,722
299,772
295,307
287,645
281,743
270,378
269,886
261,465
251,738
251,738261,465269,886270,378281,743287,645295,307299,772226,722255,554310,251313,870311,538313,279312,508312,982316,555312,821309,814285,128318,820303,846775,162778,380750,144754,131757,023762,022751,160761,917772,012770,485775,084788,875773,652790,468428,894241,888218,67147,523223,86952,337231,37958,205211,57339,832218,69346,20231,3591,35032,1911,6508,3741,9538,760
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
225,059
243,059
261,059
628,089
638,289
717,212
3,210,490
523,671
511,391
16,260
16,260
45,253
26,260
33,106
23,106
55,392
39,526
41,611
46,040
46,04041,61139,52655,39223,10633,10626,26045,25316,26016,260511,391523,6713,210,490717,212638,289628,089261,059243,059225,059000000000000000000000000000000000000
> Total Liabilities 
103,771
119,697
31,880
20,812
12,529
44,348
248,734
383,994
364,007
372,857
448,251
264,010
280,617
354,588
423,769
514,190
510,363
648,666
391,096
718,757
731,163
648,309
693,469
1,358,899
1,824,542
1,940,576
1,895,615
2,137,051
2,378,845
2,604,957
3,025,723
3,128,195
3,275,013
3,231,989
3,313,437
3,356,480
3,425,323
3,401,877
3,381,375
3,407,956
3,651,338
3,719,787
3,525,091
3,656,023
3,522,049
2,303,374
2,314,341
3,044,712
3,004,052
3,013,046
3,040,220
2,835,484
2,683,268
2,705,770
2,583,362
2,583,3622,705,7702,683,2682,835,4843,040,2203,013,0463,004,0523,044,7122,314,3412,303,3743,522,0493,656,0233,525,0913,719,7873,651,3383,407,9563,381,3753,401,8773,425,3233,356,4803,313,4373,231,9893,275,0133,128,1953,025,7232,604,9572,378,8452,137,0511,895,6151,940,5761,824,5421,358,899693,469648,309731,163718,757391,096648,666510,363514,190423,769354,588280,617264,010448,251372,857364,007383,994248,73444,34812,52920,81231,880119,697103,771
   > Total Current Liabilities 
75,166
91,092
31,880
20,812
12,529
44,348
248,734
379,518
359,657
358,751
374,302
179,549
196,658
271,207
345,417
428,172
424,892
563,742
336,718
567,877
581,196
499,255
545,329
1,229,406
801,363
898,423
851,797
1,045,224
1,228,302
1,445,452
1,826,828
1,950,276
2,072,720
2,024,392
2,064,877
2,246,946
2,161,323
2,089,394
2,129,742
2,197,689
2,465,135
3,559,188
3,398,455
3,564,184
3,438,334
2,022,987
1,924,047
1,996,032
1,987,078
1,998,538
1,898,539
1,898,539
1,749,317
1,777,477
1,715,910
1,715,9101,777,4771,749,3171,898,5391,898,5391,998,5381,987,0781,996,0321,924,0472,022,9873,438,3343,564,1843,398,4553,559,1882,465,1352,197,6892,129,7422,089,3942,161,3232,246,9462,064,8772,024,3922,072,7201,950,2761,826,8281,445,4521,228,3021,045,224851,797898,423801,3631,229,406545,329499,255581,196567,877336,718563,742424,892428,172345,417271,207196,658179,549374,302358,751359,657379,518248,73444,34812,52920,81231,88091,09275,166
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
40,000
40,000
116,000
1,288,153
1,235,744
1,100,335
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000001,100,3351,235,7441,288,153116,00040,00040,000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
40,000
40,000
116,000
1,288,153
1,235,744
1,100,335
1,100,000
1,512,126
1,560,126
1,575,234
1,581,033
1,338,285
1,151,999
1,034,499
971,916
939,640
922,736
912,636
860,208
824,021
799,156
759,656
759,656799,156824,021860,208912,636922,736939,640971,9161,034,4991,151,9991,338,2851,581,0331,575,2341,560,1261,512,1261,100,0001,100,3351,235,7441,288,153116,00040,00040,000000000000000000000000000000000000
       Accounts payable 
6,251
18,216
22,965
11,559
14,505
43,534
22,015
27,356
23,801
31,548
25,487
39,042
40,702
43,909
27,940
67,178
26,668
98,222
83,955
293,748
276,253
235,902
223,062
456,760
333,465
374,147
270,660
310,407
341,298
307,225
328,353
373,323
375,134
382,958
473,210
614,082
661,832
686,546
797,278
838,148
775,468
808,765
659,229
826,701
897,625
225,009
272,130
621,957
618,353
611,542
504,792
504,792
502,444
470,498
454,984
454,984470,498502,444504,792504,792611,542618,353621,957272,130225,009897,625826,701659,229808,765775,468838,148797,278686,546661,832614,082473,210382,958375,134373,323328,353307,225341,298310,407270,660374,147333,465456,760223,062235,902276,253293,74883,95598,22226,66867,17827,94043,90940,70239,04225,48731,54823,80127,35622,01543,53414,50511,55922,96518,2166,251
       Other Current Liabilities 
5,175
17,991
8,915
9,253
0
814
26,719
84,552
68,096
62,103
66,375
78,927
85,036
77,038
87,477
88,994
84,725
86,520
108,263
116,130
151,442
104,354
117,767
204,646
167,897
174,275
231,138
236,816
209,005
210,227
250,474
206,953
202,587
131,920
167,748
129,593
55,500
43,500
38,000
108,598
118,833
100,420
153,508
101,149
210,884
266,348
436,242
352,171
411,575
398,754
478,830
81,213
411,401
450,778
488,056
488,056450,778411,40181,213478,830398,754411,575352,171436,242266,348210,884101,149153,508100,420118,833108,59838,00043,50055,500129,593167,748131,920202,587206,953250,474210,227209,005236,816231,138174,275167,897204,646117,767104,354151,442116,130108,26386,52084,72588,99487,47777,03885,03678,92766,37562,10368,09684,55226,71981409,2538,91517,9915,175
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,264,000
1,312,483
1,251,633
1,210,267
1,186,203
160,600
126,635
91,839
83,715
280,387
390,294
1,048,680
1,016,974
1,014,508
1,010,709
936,945
933,951
928,293
867,452
867,452928,293933,951936,9451,010,7091,014,5081,016,9741,048,680390,294280,38783,71591,839126,635160,6001,186,2031,210,2671,251,6331,312,4831,264,000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
4,476
4,350
4,106
3,949
14,461
13,959
13,381
12,852
13,018
12,471
11,925
11,378
116,248
115,701
115,155
114,608
114,478
115,531
134,871
136,902
151,183
159,939
158,935
148,360
147,419
146,816
158,425
157,038
135,663
289,768
85,745
231,667
85,377
78,991
79,601
73,216
73,826
67,440
272,947
390,294
501,423
999,773
495,716
994,092
0
0
425,514
866,380
866,380425,51400994,092495,716999,773501,423390,294272,94767,44073,82673,21679,60178,99185,377231,66785,745289,768135,663157,038158,425146,816147,419148,360158,935159,939151,183136,902134,871115,531114,478114,608115,155115,701116,24811,37811,92512,47113,01812,85213,38113,95914,4613,9494,1064,3504,4760000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30,072
31,855
35,732
38,323
43,723
51,556
91,656
92,719
96,775
100,087
65,690
62,526
39,374
38,626
39,352
37,875
35,904
35,549
0
0
33,424
24,289
24,28933,4240035,54935,90437,87539,35238,62639,37462,52665,690100,08796,77592,71991,65651,55643,72338,32335,73231,85530,072000000000000000000000000000000000
> Total Stockholder Equity
233,116
917,468
937,358
971,966
986,407
992,852
967,845
996,119
1,012,017
1,024,328
1,056,302
1,851,126
1,862,121
1,881,843
1,935,449
1,974,988
2,005,146
2,013,882
3,654,097
3,703,299
3,753,324
3,793,382
3,889,890
4,416,140
4,453,864
4,483,962
4,562,495
4,639,853
4,689,915
4,727,647
4,817,709
4,912,865
4,965,933
4,982,469
5,070,958
5,187,447
5,221,715
5,176,556
5,213,890
5,230,372
5,247,181
5,246,096
5,257,590
5,237,832
5,179,108
5,741,075
5,774,454
4,433,517
4,395,454
4,323,245
4,294,701
3,614,368
3,554,542
3,506,592
3,359,038
3,359,0383,506,5923,554,5423,614,3684,294,7014,323,2454,395,4544,433,5175,774,4545,741,0755,179,1085,237,8325,257,5905,246,0965,247,1815,230,3725,213,8905,176,5565,221,7155,187,4475,070,9584,982,4694,965,9334,912,8654,817,7094,727,6474,689,9154,639,8534,562,4954,483,9624,453,8644,416,1403,889,8903,793,3823,753,3243,703,2993,654,0972,013,8822,005,1461,974,9881,935,4491,881,8431,862,1211,851,1261,056,3021,024,3281,012,017996,119967,845992,852986,407971,966937,358917,468233,116
   Common Stock
75,000
100,000
100,000
100,000
100,000
100,000
100,000
100,000
100,000
100,000
100,000
139,000
139,000
278,000
278,000
278,000
278,000
556,000
721,360
721,360
726,657
726,657
726,657
772,070
772,625
771,065
771,065
771,065
771,065
768,955
768,955
768,955
768,907
768,907
768,907
766,773
766,773
766,773
766,773
766,773
766,773
766,773
766,773
766,773
766,773
766,773
766,773
766,773
766,773
766,773
766,773
0
0
766,773
766,773
766,773766,77300766,773766,773766,773766,773766,773766,773766,773766,773766,773766,773766,773766,773766,773766,773766,773766,773768,907768,907768,907768,955768,955768,955771,065771,065771,065771,065772,625772,070726,657726,657726,657721,360721,360556,000278,000278,000278,000278,000139,000139,000100,000100,000100,000100,000100,000100,000100,000100,000100,000100,00075,000
   Retained Earnings 
122,415
124,673
143,102
163,502
175,680
184,388
159,381
178,317
194,812
206,526
238,500
258,592
269,587
261,509
315,115
346,969
415,468
424,204
501,235
550,767
566,573
606,632
703,140
721,998
760,195
788,764
866,903
946,010
996,374
1,034,935
1,126,798
1,211,735
1,267,405
1,280,184
1,366,177
1,482,626
1,424,878
1,378,201
1,413,415
1,524,509
1,540,159
1,539,364
1,553,460
1,535,157
1,475,971
2,054,522
2,087,653
731,867
694,514
618,531
586,529
-193,039
-254,483
-197,052
-344,634
-344,634-197,052-254,483-193,039586,529618,531694,514731,8672,087,6532,054,5221,475,9711,535,1571,553,4601,539,3641,540,1591,524,5091,413,4151,378,2011,424,8781,482,6261,366,1771,280,1841,267,4051,211,7351,126,7981,034,935996,374946,010866,903788,764760,195721,998703,140606,632566,573550,767501,235424,204415,468346,969315,115261,509269,587258,592238,500206,526194,812178,317159,381184,388175,680163,502143,102124,673122,415
   Capital Surplus 0000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000-13,895-13,895-13,895-14,215-14,215-14,215-28,164-28,164-28,164-28,164-38,312-34,08100000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
979
3,476
3,516
2,111
3,629
5,749
4,558
5,717
5,427
2,825
1,371
1,832
703
951
345
-364
3,409
6,868
0
0
2,340
2,368
2,3682,340006,8683,409-3643459517031,8321,3712,8255,4275,7174,5585,7493,6292,1113,5163,476979000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue404,612
Cost of Revenue-190,836
Gross Profit213,776213,776
 
Operating Income (+$)
Gross Profit213,776
Operating Expense-551,101
Operating Income-146,488-337,324
 
Operating Expense (+$)
Research Development22,388
Selling General Administrative199,359
Selling And Marketing Expenses-
Operating Expense551,101221,748
 
Net Interest Income (+$)
Interest Income137
Interest Expense-95,002
Other Finance Cost-3,800
Net Interest Income-98,666
 
Pretax Income (+$)
Operating Income-146,488
Net Interest Income-98,666
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-915,838-146,488
EBIT - interestExpense = -95,002
-931,163
-836,161
Interest Expense95,002
Earnings Before Interest and Taxes (EBIT)--820,835
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-915,838
Tax Provision-35,548
Net Income From Continuing Ops-951,386-951,386
Net Income-931,163
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-98,666
 

Technical Analysis of Guangdong Taiantang Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Guangdong Taiantang Pharmaceutical Co Ltd. The general trend of Guangdong Taiantang Pharmaceutical Co Ltd is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Guangdong Taiantang Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Guangdong Taiantang Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.64 < 2.02 < 2.2.

The bearish price targets are: .

Tweet this
Guangdong Taiantang Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Guangdong Taiantang Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Guangdong Taiantang Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Guangdong Taiantang Pharmaceutical Co Ltd. The current macd is -0.18122308.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Guangdong Taiantang Pharmaceutical Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Guangdong Taiantang Pharmaceutical Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Guangdong Taiantang Pharmaceutical Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Guangdong Taiantang Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartGuangdong Taiantang Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Guangdong Taiantang Pharmaceutical Co Ltd. The current adx is 27.87.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Guangdong Taiantang Pharmaceutical Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Guangdong Taiantang Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Guangdong Taiantang Pharmaceutical Co Ltd. The current sar is 1.66569996.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Guangdong Taiantang Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Guangdong Taiantang Pharmaceutical Co Ltd. The current rsi is 24.12. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Guangdong Taiantang Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartGuangdong Taiantang Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Guangdong Taiantang Pharmaceutical Co Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Guangdong Taiantang Pharmaceutical Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Guangdong Taiantang Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartGuangdong Taiantang Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Guangdong Taiantang Pharmaceutical Co Ltd. The current cci is -168.54223257.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Guangdong Taiantang Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartGuangdong Taiantang Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Guangdong Taiantang Pharmaceutical Co Ltd. The current cmo is -63.07550541.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Guangdong Taiantang Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartGuangdong Taiantang Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Guangdong Taiantang Pharmaceutical Co Ltd. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Guangdong Taiantang Pharmaceutical Co Ltd Daily Williams %R ChartGuangdong Taiantang Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Guangdong Taiantang Pharmaceutical Co Ltd.

Guangdong Taiantang Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Guangdong Taiantang Pharmaceutical Co Ltd. The current atr is 0.09487474.

Guangdong Taiantang Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartGuangdong Taiantang Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Guangdong Taiantang Pharmaceutical Co Ltd. The current obv is -498,084,199.

Guangdong Taiantang Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartGuangdong Taiantang Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Guangdong Taiantang Pharmaceutical Co Ltd. The current mfi is 32.75.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Guangdong Taiantang Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartGuangdong Taiantang Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Guangdong Taiantang Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-11-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-09STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-23STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-28ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-18ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-02ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-20BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-25BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.

6.3. Candlestick Patterns

Guangdong Taiantang Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Guangdong Taiantang Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5024.123
Ma 20Greater thanMa 501.733
Ma 50Greater thanMa 1002.048
Ma 100Greater thanMa 2002.361
OpenGreater thanClose1.300
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Guangdong Taiantang Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Guangdong Taiantang Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Guangdong Taiantang Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Guangdong Taiantang Pharmaceutical Co Ltd

I send you an email if I find something interesting about Guangdong Taiantang Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Guangdong Taiantang Pharmaceutical Co Ltd.

Receive notifications about Guangdong Taiantang Pharmaceutical Co Ltd in your mailbox!